Pentwater Capital Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Pentwater Capital Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-200,000	Closed	-$1.03M	–	232
2019 Q2	$1.03M	Buy	+200,000	New	+$899K	0.01%	136

Other funds holding PETX

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Pentwater Capital Management's PETX Position: Q3 2019 in Review

Pentwater Capital Management sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 200,000 shares — an estimated $1.03M sold.

Pentwater Capital Management first reported a position in PETX in Q2 2019 and held it in 1 quarter. The position peaked at $1.03M in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

Pentwater Capital Management reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
Pentwater Capital Management sold 200,000 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $1.03M.
Pentwater Capital Management first reported a position in Aratana Therapeutics, Inc. in Q2 2019 and held it in 1 quarter.
Pentwater Capital Management's Aratana Therapeutics, Inc. position peaked at $1.03M in Q2 2019.
2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Pentwater Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.